Chatwin Hannah, Holde Katrine, Wimberley Theresa, Dalsgaard Søren, Petersen Liselotte Vogdrup
National Centre for Register-Based Research (NCRR), Aarhus University, Aarhus, Denmark.
Centre for Integrated Register-Based Research at Aarhus University (CIRRAU), Aarhus University, Aarhus, Denmark.
J Child Psychol Psychiatry. 2025 Jul;66(7):994-1004. doi: 10.1111/jcpp.14113. Epub 2025 Jan 3.
More research is needed to understand psychopathology among parents of children with mental disorders in the years before and after the child is diagnosed. Here, we estimated the risk of mental disorders and psychotropic medication use in parents of children with versus without mental disorders and the temporal associations between child and parental psychopathology.
We conducted a population-based matched cohort study using Danish register data. The study population included child-parent pairs of all children diagnosed with a mental disorder of interest (attention-deficit/hyperactivity disorder, autism spectrum disorder, intellectual disability, anxiety disorder, mood disorder, eating disorder, substance use disorder, and schizophrenia spectrum disorder) by 18 years of age during the period 1999-2014 and a matched reference population. Each child with a diagnosis was matched to 10 children of the same sex and birth year who had not been diagnosed with the mental disorder of interest. For all parents, we estimated the yearly incidence proportion of parental mental disorders and prescriptions for psychotropic medications 4 years before and after the child's diagnosis.
We observed a substantially increased risk of mental disorders and psychotropic medication use among parents of children with a mental disorder, compared to the reference population. On average, parents of children with a diagnosis had twice the odds of mood disorders, anxiety disorders, and prescriptions for anti-depressants and anti-psychotics. The incidence of mood and anxiety disorders peaked in the 1-2 years before and after the child's diagnosis. The incidence of parental prescriptions for psychotropic medications (particularly anti-psychotics) peaked in the year the child was diagnosed and in the 3 years before the child's diagnosis for anti-depressants and sleep medications.
This study demonstrates clear temporal associations between child and parental psychopathology, with parental psychopathology peaking in the years immediately before and after the child's diagnosis.
需要开展更多研究以了解儿童被诊断患有精神障碍之前及之后数年中,患有精神障碍儿童的父母的精神病理学情况。在此,我们评估了患有与未患有精神障碍儿童的父母出现精神障碍及使用精神药物的风险,以及儿童与父母精神病理学之间的时间关联。
我们利用丹麦登记数据开展了一项基于人群的匹配队列研究。研究人群包括1999年至2014年期间所有在18岁前被诊断患有目标精神障碍(注意力缺陷多动障碍、自闭症谱系障碍、智力残疾、焦虑症、情绪障碍、饮食失调、物质使用障碍和精神分裂症谱系障碍)的儿童及其父母对,以及一个匹配的对照人群。每名被诊断的儿童与10名同性且同年出生、未被诊断患有目标精神障碍的儿童进行匹配。对于所有父母,我们估计了儿童诊断前后4年中父母精神障碍的年发病率以及精神药物处方率。
与对照人群相比,我们观察到患有精神障碍儿童的父母出现精神障碍及使用精神药物的风险大幅增加。平均而言,被诊断儿童的父母出现情绪障碍、焦虑症以及开具抗抑郁药和抗精神病药处方的几率是对照人群的两倍。情绪和焦虑障碍的发病率在儿童诊断前1至2年及诊断后达到峰值。父母精神药物处方(尤其是抗精神病药)的发病率在儿童被诊断当年达到峰值,而抗抑郁药和助眠药物的处方率在儿童诊断前3年达到峰值。
本研究表明儿童与父母精神病理学之间存在明确的时间关联,父母精神病理学在儿童诊断前后数年达到峰值。